RU2015136774A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2015136774A3 RU2015136774A3 RU2015136774A RU2015136774A RU2015136774A3 RU 2015136774 A3 RU2015136774 A3 RU 2015136774A3 RU 2015136774 A RU2015136774 A RU 2015136774A RU 2015136774 A RU2015136774 A RU 2015136774A RU 2015136774 A3 RU2015136774 A3 RU 2015136774A3
- Authority
- RU
- Russia
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361773773P | 2013-03-06 | 2013-03-06 | |
| US61/773,773 | 2013-03-06 | ||
| PCT/US2014/020245 WO2014138037A1 (en) | 2013-03-06 | 2014-03-04 | Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018127997A Division RU2768730C2 (ru) | 2013-03-06 | 2014-03-04 | Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2015136774A RU2015136774A (ru) | 2017-04-10 |
| RU2015136774A3 true RU2015136774A3 (enExample) | 2018-02-26 |
| RU2663911C2 RU2663911C2 (ru) | 2018-08-13 |
Family
ID=50382628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015136774A RU2663911C2 (ru) | 2013-03-06 | 2014-03-04 | Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз |
| RU2018127997A RU2768730C2 (ru) | 2013-03-06 | 2014-03-04 | Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018127997A RU2768730C2 (ru) | 2013-03-06 | 2014-03-04 | Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US9850264B2 (enExample) |
| EP (2) | EP2964213B1 (enExample) |
| JP (4) | JP6196327B2 (enExample) |
| KR (2) | KR102227201B1 (enExample) |
| CN (2) | CN105007909B (enExample) |
| AR (1) | AR095034A1 (enExample) |
| AU (3) | AU2014225992B2 (enExample) |
| BR (2) | BR112015021371B1 (enExample) |
| CA (2) | CA2898301C (enExample) |
| CL (3) | CL2015002485A1 (enExample) |
| ES (2) | ES3036990T3 (enExample) |
| IL (3) | IL241012B (enExample) |
| MX (2) | MX393070B (enExample) |
| MY (1) | MY207109A (enExample) |
| PH (3) | PH12020500285B1 (enExample) |
| RU (2) | RU2663911C2 (enExample) |
| SG (2) | SG10201801471RA (enExample) |
| TW (1) | TWI616200B (enExample) |
| WO (1) | WO2014138037A1 (enExample) |
| ZA (1) | ZA201505134B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE040145T2 (hu) * | 2011-10-26 | 2019-02-28 | Allergan Inc | N-karbamid szubsztituált aminosavak amid származékai mint formilpeptidszerû receptor 1 (FPRL1) receptormodulátorok |
| SG11201406629VA (en) * | 2012-04-16 | 2014-11-27 | Allergan Inc | (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators |
| EP2850058B1 (en) | 2012-05-16 | 2016-07-13 | Actelion Pharmaceuticals Ltd. | 1-(p-tolyl)cyclopropyl substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists |
| MA37618B1 (fr) | 2012-05-16 | 2017-08-31 | Actelion Pharmaceuticals Ltd | Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx |
| CN107312039B (zh) | 2012-08-30 | 2019-06-25 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药的制备方法 |
| AU2014226001B2 (en) | 2013-03-06 | 2018-12-06 | Allergan, Inc. | Use of agonists of Formyl peptide receptor 2 for treating dermatological diseases |
| EP2964213B1 (en) * | 2013-03-06 | 2020-11-04 | Allergan, Inc. | Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases |
| AR096686A1 (es) | 2013-06-25 | 2016-01-27 | Actelion Pharmaceuticals Ltd | Derivados de espiro[2.4]heptano puenteados sustituidos con difluoroetil-oxazol como agonistas del receptor de alx |
| KR102313757B1 (ko) * | 2013-07-16 | 2021-10-18 | 알러간, 인코포레이티드 | 펩타이드 수용체 조절제로서의 n-우레아 치환된 아미노산의 유도체 |
| BR112016001106A8 (pt) | 2013-07-18 | 2017-12-26 | Actelion Pharmaceuticals Ltd | Derivados de espiro [2,4] heptano interligados piperazina substituídos como agonistas do receptor de alx |
| AR097279A1 (es) | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
| US9663457B2 (en) | 2014-04-09 | 2017-05-30 | Allergan, Inc. | Carbamoyl hydrazine derivatives as formyl peptide modulators |
| KR20170005121A (ko) | 2014-05-21 | 2017-01-11 | 알러간, 인코포레이티드 | 폼일 펩타이드 수용체 조절제로서의 이미다졸 유도체 |
| EP3271327A4 (en) | 2015-03-19 | 2018-11-21 | University of Maryland, Baltimore | Runx2 transcription factor inhibitors and uses thereof |
| WO2016189877A1 (en) | 2015-05-27 | 2016-12-01 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| AU2017241767B2 (en) * | 2016-03-28 | 2021-07-22 | Allergan, Inc. | Phenyl urea derivatives as N-formyl peptide receptor modulators |
| WO2017180323A1 (en) * | 2016-04-12 | 2017-10-19 | Allergan, Inc. | Phenyl urea derivatives as n-formyl peptide receptor modulators |
| TWI746660B (zh) | 2016-10-06 | 2021-11-21 | 日商第一三共股份有限公司 | 尿素衍生物及其用途 |
| CN109134533B (zh) | 2017-06-27 | 2020-08-11 | 维眸生物科技（上海）有限公司 | 一种含磷化合物及其制备和应用 |
| CN107814773B (zh) * | 2017-11-13 | 2020-05-22 | 西安交通大学 | 含有喹唑啉酮的二芳基脲类化合物及其制备方法和应用 |
| RU2712229C2 (ru) * | 2018-05-17 | 2020-01-27 | Закрытое акционерное общество "Институт экспериментальной фармакологии" | Эфиры тригидроксигептаеновой кислоты в качестве агонистов fpr2 рецептора |
| KR102429281B1 (ko) * | 2020-05-25 | 2022-08-05 | (주)노바셀테크놀로지 | 신규 안구건조증 치료용 약학적 조성물 |
| IT202100004964A1 (it) * | 2021-03-03 | 2022-09-03 | Univ Degli Studi Di Bari Aldo Moro | Agonisti del recettore fpr2 (formyl peptide receptor 2) e loro uso nel trattamento del disturbo dello spettro autistico. |
| JP2022151437A (ja) * | 2021-03-26 | 2022-10-07 | 均 石井 | 網膜炎治療薬。 |
| WO2025233915A1 (en) * | 2024-05-10 | 2025-11-13 | Allgenesis Biotherapeutics Inc. | Use of an agonist of formyl peptide receptors 1 and 2 for treating ocular inflammatory diseases |
| WO2025239980A1 (en) * | 2024-05-13 | 2025-11-20 | University Of Virginia Patent Foundation | Compounds for the inhibition of kifc3, methods of making the same, and pharmaceutical compositions comprising the same |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4521210A (en) | 1982-12-27 | 1985-06-04 | Wong Vernon G | Eye implant for relieving glaucoma, and device and method for use therewith |
| JPS63232846A (ja) | 1987-03-20 | 1988-09-28 | Haruo Ogura | 新規な固定相担体 |
| AU667995B2 (en) * | 1993-02-15 | 1996-04-18 | Bayer Aktiengesellschaft | New pseudopeptides having an antiviral action |
| US6423689B1 (en) * | 1997-12-22 | 2002-07-23 | Warner-Lambert Company | Peptidyl calcium channel blockers |
| AU6909300A (en) * | 1999-08-20 | 2001-03-19 | Merck & Co., Inc. | Substituted ureas as cell adhesion inhibitors |
| EP1162194A1 (en) | 2000-06-06 | 2001-12-12 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| DE10063008A1 (de) * | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
| CA2495284A1 (en) | 2002-09-05 | 2004-03-18 | Neurosearch A/S | Diarylurea derivatives and their use as chloride channel blockers |
| US7943137B2 (en) * | 2002-11-07 | 2011-05-17 | Takeda Pharmaceutical Company Limited | FPRL1 ligands and use thereof |
| US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| WO2005047899A2 (en) | 2003-11-07 | 2005-05-26 | Acadia Pharmaceuticals Inc. | Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| WO2005058823A1 (ja) | 2003-12-17 | 2005-06-30 | Takeda Pharmaceutical Company Limited | ウレア誘導体、その製造法及び用途 |
| WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
| WO2007076055A2 (en) * | 2005-12-22 | 2007-07-05 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| US20080008694A1 (en) * | 2006-07-05 | 2008-01-10 | Elgebaly Salwa A | Methods to prevent and treat diseases |
| EP2492278A1 (en) * | 2006-09-18 | 2012-08-29 | Compugen Ltd. | Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy |
| EP2242747A1 (de) | 2008-02-07 | 2010-10-27 | Sanofi-Aventis | Substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung |
| US20100035932A1 (en) * | 2008-08-07 | 2010-02-11 | Schepetkin Igor A | Novel formyl peptide receptor like 1 agonists that induce macrophage tumor necrosis factor alpha and computational structure-activity relationship analysis of thereof |
| WO2010104306A2 (ko) * | 2009-03-07 | 2010-09-16 | 주식회사 메디젠텍 | 세포핵에서 세포질로의 ｇｓｋ３의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 ｇｓｋ３ 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물 |
| EP2585054A1 (en) | 2010-06-24 | 2013-05-01 | Allergan, Inc. | Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| AU2011336973A1 (en) * | 2010-12-03 | 2013-07-11 | Allergan, Inc. | Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity |
| WO2012109544A1 (en) | 2011-02-11 | 2012-08-16 | Allergan, Inc. | Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
| US8653299B2 (en) | 2011-03-17 | 2014-02-18 | Allergan, Inc. | Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| US20120329873A1 (en) | 2011-06-17 | 2012-12-27 | Li yong-xin | D-serine for the treatment of visual system disorders |
| EP2731931A1 (en) | 2011-07-11 | 2014-05-21 | Allergan, Inc. | Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| HUE040145T2 (hu) * | 2011-10-26 | 2019-02-28 | Allergan Inc | N-karbamid szubsztituált aminosavak amid származékai mint formilpeptidszerû receptor 1 (FPRL1) receptormodulátorok |
| US8541577B2 (en) | 2011-11-10 | 2013-09-24 | Allergan, Inc. | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators |
| US8492556B2 (en) * | 2011-11-10 | 2013-07-23 | Allergan, Inc. | 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| EP2814815A1 (en) | 2012-02-16 | 2014-12-24 | Allergan, Inc. | Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators |
| SG11201406629VA (en) | 2012-04-16 | 2014-11-27 | Allergan Inc | (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators |
| EP2964213B1 (en) | 2013-03-06 | 2020-11-04 | Allergan, Inc. | Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases |
-
2014
- 2014-03-04 EP EP14712888.8A patent/EP2964213B1/en active Active
- 2014-03-04 AU AU2014225992A patent/AU2014225992B2/en active Active
- 2014-03-04 CN CN201480012204.5A patent/CN105007909B/zh active Active
- 2014-03-04 CN CN201910497947.0A patent/CN110279684B/zh active Active
- 2014-03-04 ES ES20205401T patent/ES3036990T3/es active Active
- 2014-03-04 CA CA2898301A patent/CA2898301C/en active Active
- 2014-03-04 MX MX2019005541A patent/MX393070B/es unknown
- 2014-03-04 BR BR112015021371-5A patent/BR112015021371B1/pt active IP Right Grant
- 2014-03-04 KR KR1020157024036A patent/KR102227201B1/ko active Active
- 2014-03-04 ES ES14712888T patent/ES2835825T3/es active Active
- 2014-03-04 MX MX2015011593A patent/MX364916B/es active IP Right Grant
- 2014-03-04 BR BR122017004254-8A patent/BR122017004254B1/pt active IP Right Grant
- 2014-03-04 SG SG10201801471RA patent/SG10201801471RA/en unknown
- 2014-03-04 KR KR1020207023766A patent/KR102290134B1/ko active Active
- 2014-03-04 US US14/196,047 patent/US9850264B2/en active Active
- 2014-03-04 PH PH1/2020/500285A patent/PH12020500285B1/en unknown
- 2014-03-04 RU RU2015136774A patent/RU2663911C2/ru active
- 2014-03-04 RU RU2018127997A patent/RU2768730C2/ru active
- 2014-03-04 CA CA3133264A patent/CA3133264A1/en active Pending
- 2014-03-04 EP EP20205401.1A patent/EP3795148B1/en active Active
- 2014-03-04 SG SG11201507113RA patent/SG11201507113RA/en unknown
- 2014-03-04 JP JP2015561536A patent/JP6196327B2/ja active Active
- 2014-03-04 MY MYPI2019001743A patent/MY207109A/en unknown
- 2014-03-04 WO PCT/US2014/020245 patent/WO2014138037A1/en not_active Ceased
- 2014-03-06 AR ARP140100732A patent/AR095034A1/es not_active Application Discontinuation
- 2014-03-06 TW TW103107761A patent/TWI616200B/zh active
-
2015
- 2015-07-16 ZA ZA2015/05134A patent/ZA201505134B/en unknown
- 2015-08-24 PH PH12015501858A patent/PH12015501858A1/en unknown
- 2015-09-01 IL IL241012A patent/IL241012B/en active IP Right Grant
- 2015-09-04 CL CL2015002485A patent/CL2015002485A1/es unknown
-
2017
- 2017-07-21 US US15/656,766 patent/US10208071B2/en active Active
- 2017-08-17 JP JP2017157335A patent/JP6496786B2/ja active Active
- 2017-08-17 JP JP2017157334A patent/JP6602351B2/ja active Active
- 2017-10-06 CL CL2017002526A patent/CL2017002526A1/es unknown
- 2017-10-06 CL CL2017002527A patent/CL2017002527A1/es unknown
-
2018
- 2018-05-28 AU AU2018203719A patent/AU2018203719B2/en active Active
- 2018-11-27 IL IL263314A patent/IL263314B/en active IP Right Grant
-
2019
- 2019-01-22 US US16/254,438 patent/US10899780B2/en active Active
- 2019-03-11 JP JP2019043934A patent/JP6672500B2/ja active Active
- 2019-09-06 AU AU2019226215A patent/AU2019226215B2/en active Active
-
2020
- 2020-02-07 PH PH12020500286A patent/PH12020500286A1/en unknown
- 2020-03-11 IL IL273208A patent/IL273208A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021000792B8 (enExample) | ||
| AT524874A5 (enExample) | ||
| AT524834A2 (enExample) | ||
| AU2018438767B1 (enExample) | ||
| AT521543A3 (enExample) | ||
| BR102019026286B1 (pt) | Método e aparelho para o avanço de produtos a serem moldados | |
| BR102019025884B1 (pt) | Sistema de segurança aprimorado para máquinas de operação de autopropulsão | |
| BR102019023514B1 (pt) | Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna | |
| BR112021001434B1 (pt) | Aço com alto teor de manganês e método de produção do mesmo | |
| BR112021001374B1 (pt) | Composição farmacêutica para o tratamento da hipertensão e seu uso | |
| BR112021001128B1 (pt) | Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit | |
| BR112021001186B1 (pt) | Aparelho para o tratamento de celulite para tratar expressões de celulite na pele de um paciente associadas a um local de tratamento de septos | |
| BR112021000922B1 (pt) | Tela de filtro, e, método para purificar água de alimentação | |
| BR112020023832B1 (pt) | Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral | |
| BR112020024987B1 (pt) | Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico | |
| BR112020023823B1 (pt) | Distribuidor | |
| BR112020022482B1 (pt) | Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico | |
| BR112020022658B1 (pt) | Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido | |
| BR112020022516B1 (pt) | Processo para degomagem enzimática de óleo | |
| BR112020021042B1 (pt) | Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas | |
| BR112020020812B1 (pt) | Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado | |
| BR112020020476B1 (pt) | Filtro prensa e processo para operação de filtro prensa | |
| BR102019000241B1 (pt) | Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados | |
| BR102018073077B1 (pt) | Processo de extração de gelatina de resíduos de couro curtido ao cromo wet blue | |
| BR112020022381B1 (pt) | Terminal para desempenhar um procedimento de acesso aleatório baseado em contenção para solicitação de informações de sistema e método relacionado |